255 related articles for article (PubMed ID: 21483741)
1. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
[TBL] [Abstract][Full Text] [Related]
2. Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.
Remédio L; Carvalho T; Caiado F; Bastos-Carvalho A; Martins D; Duarte A; Yagita H; Dias S
PLoS One; 2012; 7(12):e52450. PubMed ID: 23285048
[TBL] [Abstract][Full Text] [Related]
3. Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade.
Yamanda S; Ebihara S; Asada M; Okazaki T; Niu K; Ebihara T; Koyanagi A; Yamaguchi N; Yagita H; Arai H
Blood; 2009 Apr; 113(15):3631-9. PubMed ID: 19218547
[TBL] [Abstract][Full Text] [Related]
4. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion.
Ubezio B; Blanco RA; Geudens I; Stanchi F; Mathivet T; Jones ML; Ragab A; Bentley K; Gerhardt H
Elife; 2016 Apr; 5():. PubMed ID: 27074663
[TBL] [Abstract][Full Text] [Related]
5. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.
Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL
Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154
[TBL] [Abstract][Full Text] [Related]
6. Delta-like ligand 4-Notch signaling regulates bone marrow-derived pericyte/vascular smooth muscle cell formation.
Stewart KS; Zhou Z; Zweidler-McKay P; Kleinerman ES
Blood; 2011 Jan; 117(2):719-26. PubMed ID: 20944072
[TBL] [Abstract][Full Text] [Related]
7. Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
Hu W; Lu C; Dong HH; Huang J; Shen DY; Stone RL; Nick AM; Shahzad MM; Mora E; Jennings NB; Lee SJ; Roh JW; Matsuo K; Nishimura M; Goodman BW; Jaffe RB; Langley RR; Deavers MT; Lopez-Berestein G; Coleman RL; Sood AK
Cancer Res; 2011 Sep; 71(18):6030-9. PubMed ID: 21795478
[TBL] [Abstract][Full Text] [Related]
8. Delta-like 4/Notch signaling promotes Apc
Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
[TBL] [Abstract][Full Text] [Related]
9. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma.
Schadler KL; Zweidler-McKay PA; Guan H; Kleinerman ES
Clin Cancer Res; 2010 Feb; 16(3):848-56. PubMed ID: 20103680
[TBL] [Abstract][Full Text] [Related]
10. Endothelial immune activation programmes cell-fate decisions and angiogenesis by inducing angiogenesis regulator DLL4 through TLR4-ERK-FOXC2 signalling.
Xia S; Menden HL; Korfhagen TR; Kume T; Sampath V
J Physiol; 2018 Apr; 596(8):1397-1417. PubMed ID: 29380370
[TBL] [Abstract][Full Text] [Related]
11. The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow.
Lobov IB; Cheung E; Wudali R; Cao J; Halasz G; Wei Y; Economides A; Lin HC; Papadopoulos N; Yancopoulos GD; Wiegand SJ
Blood; 2011 Jun; 117(24):6728-37. PubMed ID: 21498671
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos.
Trindade A; Kumar SR; Scehnet JS; Lopes-da-Costa L; Becker J; Jiang W; Liu R; Gill PS; Duarte A
Blood; 2008 Sep; 112(5):1720-9. PubMed ID: 18559979
[TBL] [Abstract][Full Text] [Related]
13. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching.
Wei Y; Gong J; Thimmulappa RK; Kosmider B; Biswal S; Duh EJ
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3910-8. PubMed ID: 24062466
[TBL] [Abstract][Full Text] [Related]
15. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
16. Delta-like ligand 4-notch blockade and tumor radiation response.
Liu SK; Bham SA; Fokas E; Beech J; Im J; Cho S; Harris AL; Muschel RJ
J Natl Cancer Inst; 2011 Dec; 103(23):1778-98. PubMed ID: 22010178
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
Purhonen S; Palm J; Rossi D; Kaskenpää N; Rajantie I; Ylä-Herttuala S; Alitalo K; Weissman IL; Salven P
Proc Natl Acad Sci U S A; 2008 May; 105(18):6620-5. PubMed ID: 18443294
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.
Harjes U; Bridges E; McIntyre A; Fielding BA; Harris AL
J Biol Chem; 2014 Aug; 289(33):23168-23176. PubMed ID: 24939870
[TBL] [Abstract][Full Text] [Related]
19. Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes.
Skuli N; Majmundar AJ; Krock BL; Mesquita RC; Mathew LK; Quinn ZL; Runge A; Liu L; Kim MN; Liang J; Schenkel S; Yodh AG; Keith B; Simon MC
J Clin Invest; 2012 Apr; 122(4):1427-43. PubMed ID: 22426208
[TBL] [Abstract][Full Text] [Related]
20. IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4.
Deng J; Liu X; Rong L; Ni C; Li X; Yang W; Lu Y; Yan X; Qin C; Zhang L; Qin Z
J Pathol; 2014 Jun; 233(2):170-82. PubMed ID: 24615277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
